VOLTAGE-GATED Ca 2ϩ (Ca v ) channels are involved in a multitude of processes, including excitability, exocytosis, metabolism, and gene expression (Catterall 2000; Dolphin 2006; Hofmann et al. 1999; Lacinova 2005) . They are divided into two subfamilies, namely, low voltage-activated and high voltage-activated Ca 2ϩ channels (HVACCs). The latter usually require depolarization to about Ϫ20 mV to open (Carbone and Lux 1987; Fox et al. 1987; Randall and Tsien 1995) and comprise L-, N-, P/Q-, and R-type channels (Tsien et al. 1988 ). P/Q-and N-type HVACCs are sensitive to -agatoxin IVA (Mintz et al. 1992) and -conotoxin GVIA, respectively (Boland et al. 1994; McCleskey et al. 1987) , whereas R-type channels are resistant to those blockers as well as to dihydropyridines (DHPs) (Randall and Tsien 1995) . L-type channels are highly sensitive to DHPs and are further subdivided on the basis of four different pore-forming ␣ 1 -subunits named Ca v 1.1-Ca v 1.4 (Catterall et al. 2005; Ertel et al. 2000; Striessnig and Koschak 2008) . Ca v 1.2 and Ca v 1.3 subunits coexist in many tissues, including central nervous system neurons (Hell et al. 1993 ). In the mouse brain, Ca v 1.3 accounts for 11% of L-type Ca 2ϩ channels (Sinnegger-Brauns et al. 2009 ). Ca v 1.3 channels are unusual in that they are activated at more negative voltages than Ca v 1.2 channels [Ϫ46 vs. Ϫ32 mV (Koschak et al. 2001) or Ϫ55 vs. Ϫ30 to Ϫ25 mV (Lipscombe et al. 2004) ], thus allowing long-lasting Ca 2ϩ influx in response to relatively weak depolarizing pulses, which may be of developmental significance.
In the peripheral auditory system of mammals, Ca v 1.3 channel function is crucially important for transmitter vesicle fusion and subsequent glutamate release from cochlear inner hair cells (IHCs) onto auditory nerve fibers (Brandt et al. 2003; . Moreover, Ca 2ϩ influx through Ca v 1.3 channels is necessary for generating spontaneous action potentials in immature IHCs (Tritsch et al. 2010; Tritsch and Bergles 2010) . Deletion of Ca v 1.3 channels leads to deafness (Baig et al. 2011; Brandt et al. 2003; Platzer et al. 2000) , and due to the missing glutamate release from IHCs, cochlea-driven activation of subsequent auditory brain stem regions (spontaneous or sound driven) is completely abolished (Fig. 1A ). This abolishment also drastically affects the superior olivary complex (SOC), which comprises a group of interrelated nuclei whose neurons play essential roles in sound localization. Remarkably, SOC nuclei of Ca v 1.3 Ϫ/Ϫ mice, particularly the lateral superior olive (LSO), display severe morphological and physiological defects (Hirtz et al. 2011) . These defects may be caused by the loss of Ca v 1.3 channels in IHCs and thus by lacking peripheral input. Alternatively, and not mutually exclusive, on-site loss of the channels in LSO neurons themselves may cause the defects. Interestingly, L-type channel-mediated Ca 2ϩ influx is essential for the proper development of SOC connectivity and contributes to preserve the inhibitory projection between the medial nucleus of the trapezoid body and the LSO, as demonstrated in organotypic slice cultures (Lohmann et al. 1998) . The nature of the L-type channels, however, was not specified further, and, as yet, there is no comprehensive electrophysiological characterization of Ca v 1.3 channels and other HVACCs in LSO neurons.
The present study predominantly aimed at the identification of functional Ca v 1.3 channels in LSO neurons of wild-type (WT) mice. Our analysis also covered other HVACCs to determine their contribution to the total Ca 2ϩ current (I Ca ). In addition, we assessed whether LSO neurons of Ca v 1.3 Ϫ/Ϫ mice show any compensatory responses, i.e., upregulation of other HVACCs. As subtype-selective blockers for Ca v 1.3 and Ca v 1.2 channels do not exist Zuccotti et al. 2011) , the relative contribution of each isoform to L-type channel-mediated function cannot be assessed directly. To circumvent this problem, we used Ca v 1.2 DHP-insensitive (Ca v 1.2DHP Ϫ/Ϫ ) mice, in which a point mutation in the DHPbinding site removes the high affinity for DHP L-type Ca 2ϩ channel blockers (Sinnegger-Brauns et al. 2004) . By analyzing both neonatal and juvenile animals, we finally addressed a putative role of individual HVACCs during early development.
MATERIALS AND METHODS
Animals. C57BL/6N WT, Ca v 1.3 Ϫ/Ϫ , and Ca v 1.2DHP Ϫ/Ϫ mice of both sexes were used. Both mutant strains were bred on a C57BL6/N background. To assess developmental aspects, two age groups were analyzed: postnatal day 4 Ϯ 1 (the day of birth was taken as postnatal day 0) and postnatal day 12 Ϯ 1 (hereafter abbreviated as P4 and P12). Animals were housed in our animal facility under standard conditions with a 12:12-h light-dark cycle. Water and food were freely available. This study was conducted in accordance with National Institutes of Health guidelines for the use and care of laboratory animals. All protocols were in compliance with the German Animal Protection Law and were approved by the regional animal care and use committees.
Preparation of acute brain stem slices. Mice were decapitated, and their brains were rapidly removed and dissected in ice-cold preparation solution containing (in mM) 25 NaHCO 3 , 1.25 NaH 2 PO 4 , 2.5 KCl, 1 MgCl 2 , 2 CaCl 2 , 260 D-glucose, 2 sodium pyruvate, 3 myoinositol, and 1 kynurenic acid. Therein, the brain stem containing the LSO was isolated and cut into 270-m-thick coronal slices (3-5 slices/animal) with a vibratome (VT-1000S, Leica, Wetzlar, Germany). Slices were transferred into a storing solution containing (in mM) 125 NaCl, 25 NaHCO 3 , 1.25 NaH 2 PO 4 , 2. (50 M) . Numbers in the bars are numbers of neurons analyzed. **P Ͻ 0.01; ***P Ͻ 0.001.
CaCl 2 , 10 D-glucose, 2 sodium pyruvate, 3 myo-inositol, and 0.4 ascorbic acid, incubated at 37°C for 1 h, and thereafter maintained at room temperature until further use. Solutions were continuously bubbled with a 95% O 2 -5% CO 2 gas mixture to oxygenate the tissue and to achieve a pH of 7.4.
Electrophysiology. Slices were submerged in a recording chamber continuously perfused with O 2 /CO 2 -gassed extracellular recording solution composed of (in mM) 110 NaCl, 1 MgCl 2 , 2 CaCl 2 , 5 CsCl, 35 tetraethylammonium (TEA)-Cl, 15 4-aminopyridine, 10 D-glucose, and 10 HEPES (pH 7.4). Solutions were applied by a gravity-fed perfusion system at a rate of ϳ2 ml/min. The recording chamber was mounted on an upright microscope (Eclipse E600FN, Nikon, Tokyo, Japan) equipped with a Nikon Fluor ϫ60 DIC H water-immersion objective and infrared differential interference contrast optics. Slices were illuminated with near-infrared light, and LSO neurons were visualized using an infrared-sensitive video camera system (chargecoupled device camera C5405-01, Hamamatsu, Herrsching, Germany). LSO neurons were identified by their location, orientation, size, and spindle-shaped somata. Measurements were performed only on morphologically intact neurons. Patch pipettes were pulled from borosilicate glass capillaries (GB150F-8P, Science Products, Hofheim, Germany) using a horizontal puller (P-2000, Sutter Instruments) and had resistances of 2.5-4.5 M⍀ when filled with intracellular solution containing (in mM) 130 CsCl, 0.1 CaCl 2 , 2 MgCl 2 , 10 EGTA, 10 HEPES, 10 TEA-Cl, 0.3 Na 2 GTP, and 2 Na 2 ATP; pH was adjusted to 7.2 with CsOH (osmolarity: 290 -300 mosM). Liquid junction potentials were calculated using the JPCalc program by Barry (1994); as they amounted to Ϫ5.3 mV, they were not corrected. All experiments were performed in the tight-seal whole cell configuration of the patch-clamp technique. Recordings were conducted with an Axopatch-1D amplifier (Molecular Devices, Union City, CA). Data were sampled at 5 kHz, low-pass filtered at 10 kHz, and analyzed using pClamp and ClampFit 8.2.0.235 (Axon Instruments, Union City, CA) and Origin software (Origin Lab). Capacitive current transients were electronically compensated online, and the whole cell capacitance was estimated from this compensation. Raw currents were corrected online for linear leak currents. Throughout the experiments, the series resistance was monitored and ranged between 6 and 20 M⍀. It was routinely compensated by 60 -80%. If it exceeded 20 M⍀, recordings were excluded from further analysis. Current-voltage relations were determined using a series of 100-ms depolarizing pulses applied at a frequency of 8 Hz, which started from a holding potential of Ϫ70 mV and stepped to ϩ70 mV (ϩ40 mV in P12 Cd 2ϩ and nifedipine experiments) with increments of 10 mV (cf. Fig. 1C) . To compare the activation of currents, data were fitted with a Boltzmann equation of the following form:
is the amplitude of the current activated by the depolarizing pulse to the membrane voltage (V), V rev is the reversal potential, g max is the maximal slope conductance, V 1/2 is the voltage at which there is half-maximal activation, and dV is the activation slope factor. The current traces shown in Figs. 2-8 represent graphical averages obtained from three single traces. Blockersensitive current traces are shown as the graphical difference between the currents obtained under control conditions and in the presence of the drug. For each neuron, the maximal amplitude that occurred in all current traces was determined and used for further quantitative analysis. In the following, these amplitudes will be called "peak amplitudes." Because considerable variability in whole cell capacitance occurred with age, peak currents were normalized to whole cell capacitances [peak current density of I Ca (in pA/pF)] when developmental comparisons were made (cf. Fig. 9 ).
Pharmacological compounds. All chemicals were purchased from Sigma-Aldrich (Munich, Germany) unless stated otherwise. To block voltage-activated Na ϩ currents, all experiments were carried out in the presence of 0.5 M tetrodotoxin (Ascent Scientific, Bristol, UK). K ϩ channel-mediated currents were minimized by the combination of external/internal TEA and internal Cs. In some experiments, Cd 2ϩ (50 M CdCl 2 ) was added to inhibit I Ca . HVACCs were isolated and analyzed using specific blockers added to the extracellular recording solution. Nifedipine was purchased from RBI Research Biochemicals (Natick, USA) and used to block L-type channels. Isradipine and -conotoxin GVIA were purchased from Ascent Scientific and used to block L-and N-type channels, respectively. All blockers were prepared as stock solutions dissolved in ethanol (nifedipine and isradipine at 10 mM) or distilled water (-agatoxin IVA at 100 M and -conotoxin GVIA at 329 M) and stored at Ϫ20°C. Stock solutions were diluted to their final concentrations [nifedipine (20 M), isradipine (3 M), -agatoxin IVA (600 nM), and -conotoxin GVIA (2 M)] in extracellular recording solution and applied via a custom-made application pipette placed in the recording chamber close to the slice. Biocytin fills. To correlate the structural and functional properties of the recorded cells, biocytin was sporadically added to the intracellular solution at a final concentration of 0.5%. Typically, only one neuron was filled per slice. During the whole cell recordings, biocytin diffused into the cell soma and the cellular processes. After the pipette was detached from the soma, slices were maintained in the recording chamber for 30 min to optimize the quality of the labeling. Thereafter, they were transferred into 4% buffered paraformaldehyde and fixed overnight. They were then rinsed and incubated for 40 min with 1% H 2 O 2 and 0.5% Triton X-100 in PBS to inhibit endogenous peroxidases and increase permeability. After another rinsing step, slices were incubated for 1 h in blocker solution (3% BSA, 10% goat serum, and 0.3% Triton X-100 in Tris-buffered saline; pH 7.4) with NeutrAvidinhorseradish peroxidase conjugate (1:1,000, Molecular Probes). After slices had been rinsed in 0.5% Triton X-100-PBS, the diaminobenzidine/H 2 O 2 reaction was performed using Fast diaminobenzidine tablets. The reaction product was intensified with nickel ammonium sulfate [NiSO 4 (NH 4 ) 2 SO 4 ·6H 2 O]. Finally, slices were dehydrated, mounted on gelatine-coated slides, and enclosed with coverslips. Biocytin-diaminobenzidine-labeled LSO neurons were analyzed and photographed on an Axioskop 2 (Zeiss, Jena, Germany) with ϫ5 and ϫ40 objectives. Cell morphology was reconstructed using Cell F software (Olympus, Hamburg, Germany) and Corel Photopaint X4 and Corel Draw X4 software (Corel, Unterschlei␤heim, Germany).
RNA extraction, reverse transcription, and quantitative PCR. Total RNA was isolated from LSOs of WT and Ca v 1.3 Ϫ/Ϫ mice at P12. LSOs were dissected from acute brain stem slices and prepared as described above for electrophysiological experiments. Isolated LSOs were stored in RNAlater (Ambion, Darmstadt, Germany) at Ϫ20°C. Due to the small sample amount, eight LSO excisions were pooled for each sample from a minimum of three animals. Total RNA isolation was performed using the RNeasy Lipid Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The amount of isolated RNA was measured with a NanoDrop D-1000 UV/Visspectrophotometer (Peqlab, Erlangen, Germany). The quality of isolated RNA was assessed using a 2100 Bioanalyzer (Agilent, Böblin-gen, Germany). Isolated total RNA was used to prepare cDNA. For each sample, at least 600 ng of total RNA were reverse transcribed using random hexamers (MBI Fermentas, St. Leon-Rot, Germany). Quantitative PCR was performed with Taqman Gene Expression assays (Applied Biosystems) as previously described (SinneggerBrauns et al. 2009 ). Assay GenBank accession numbers were as follows: Ca v 1.2 ␣ 1 -subunit, Mm00437917_m1; Ca v 1.3-42a (recognizing the short COOH-terminal Ca v 1.3 splice variant), custom designed (forward primer: 5=-GGAAGTACCCTGCGAAGAACAC-3=, reverse primer: 5=-CTCAGGCAGAGAACTCTAAAGCAT-3=; and probe: 5=-TTGC-CCTACAGATGCTTG-3=); Ca v 1.3-49 (recognizing full-length transcripts), Mm01209927_g1; Ca v 2.1 and Ca v 2.2, Mm01284736_m1; Ca v 2.3, Mm0494444_m1; and GAPDH, Mm99999915_g1. Differences in gene expression between WT and Ca v 1.3 Ϫ/Ϫ mice were determined with ⌬⌬C t analysis (where C t is threshold cycle) using GAPDH as the reference gene. Slopes of relative standard curves were obtained for calculation using dilutions of whole brain cDNA (0.0005-50 ng RNA equivalents) as templates. Because of the insignificant variations in the slope values, a mean slope value (Ϫ3.1) could be used for ⌬⌬C t calculations. All experimental data points were obtained as triplicates.
Statistics. Box-and-whisker plots show the mean value of the peak amplitudes (black or white squares), the median (horizontal line), and the 25th and 75th percentiles as well as whiskers from the 5th to the 95th percentile. Data from individual neurons are shown by filled black circles. To assess for statistical significance (Winstat, R. Fitch Software, Bad Krozingen, Germany), all data sets were checked for Gaussian distribution, and outliers (Ͼ4 times SD above/below the mean) were excluded. Values in bar charts are presented as means Ϯ SE. Usually, a paired or an unpaired two-tailed Student's t-test was performed. A Mann-Whitney U-test was used to compare differences when data did not follow a normal distribution (explicitly mentioned in the text).
RESULTS

Identification and functional characterization of LSO neurons.
Experiments were performed on LSO neurons in brain stem slices of P12 and P4 WT, Ca v 1. Whole cell patch-clamp recordings of membrane currents in LSO neurons were performed using an adequate activation protocol ( Fig. 1C , inset) with external and internal solutions that effectively isolated Ca 2ϩ channel currents (cf. MATERIALS AND METHODS). Inward currents were activated at membrane potentials of about Ϫ50 mV, reached their peak amplitudes at Ϫ10 to 0 mV, and lasted until the end of the voltage step (Fig. 1C) . Upon bath application of Cd 2ϩ , a nonspecific Ca 2ϩ channel blocker (Hagiwara and Byerly 1981) , the peak amplitude of I Ca decreased significantly from Ϫ861.9 Ϯ 210.1 to Ϫ172.8 Ϯ 46.6 pA in WT neurons (81.8 Ϯ 1.5%, n ϭ 9, P ϭ 0.003) and from Ϫ465.7 Ϯ 35.5 to Ϫ76.9 Ϯ 10.3 pA in Ca v 1.3 Ϫ/Ϫ neurons (84.2 Ϯ 1.8%, n ϭ 18, P ϭ 5.1 e Ϫ10 ), indicating that the majority of current was carried by Ca 2ϩ in both genotypes (Fig. 1D ). Because T-type channels are activated by weak depolarization and are transient, in contrast to HVACCs (Catterall et al. 2005) , and because Cd 2ϩ reduces L-and N-type currents significantly more efficiently than T-type currents , the observed currents in LSO neurons were likely mediated predominantly by HVACCs. To further distinguish between various HVACC subtypes, specific channel blockers were used to block the following channels: the DHPs nifedipine and isradipine for L-type channels, the spider toxin -agatoxin IVA for P/Q-type channels, and the snail toxin -conotoxin GVIA for N-type channels (Catterall et al. 2005) .
I Ca mediated by L-type channels in P12 mice. In the brain, L-type currents are mediated by two different channel isoforms, namely, Ca v 1.2 and Ca v 1.3 (Sinnegger-Brauns et al. 2009 ). Unfortunately, specific blockers of L-type channels, capable of distinguishing between the two isoforms, do not exist, generating a major obstacle (Striessnig et al. 2006 (Fig. 2, A-F) . In WT mice, the reduction of the I Ca peak amplitude by nifedipine ranged from 24% to 73%, with a mean value of 45.0 Ϯ 4.9% (n ϭ 11; Fig. 2, G and H) . It was statistically significant (P ϭ 1.6 e Ϫ6 ), demonstrating the efficacy of the blocker. In Ca v 1.2DHP Ϫ/Ϫ mice, the reduction of I Ca was 4 -47%, with a mean of 30.1 Ϯ 3.8% (n ϭ 10, P ϭ 9 e Ϫ4 ; Fig. 2, G and H) , implying that 30% of I Ca is carried through Ca v 1.3 channels in WT LSO neurons at P12. Consequently, ϳ15% of I Ca is mediated through Ca v 1.2 channels. In Ca v 1.3 Ϫ/Ϫ mice, nifedipine reduced I Ca by 2-45%, with a mean value of 20.2 Ϯ 3.8% (n ϭ 12, P ϭ 3 e Ϫ4 ; Fig. 2 , G and H). Moreover, for both mutants, the blockade was significantly lower (P ϭ 6 e Ϫ4 and P ϭ 0.028) than in WT neurons (Fig. 2, G and H) . Together, these results indicate that ϳ45% of I Ca in WT LSO neurons at P12 is carried by L-type channels, of which 30% contribute to Ca v 1.3 subunits and the remaining 15% to Ca v 1.2 subunits.
To corroborate the nifedipine results, a second set of experiments was performed in which nifedipine was replaced by isradipine (3 M), another highly specific DHP antagonist (Koschak et al. 2001; Striessnig et al. 1998 ). Again, isradipine was applied to WT, Ca v 1.3 Ϫ/Ϫ , and Ca v 1.2DHP Ϫ/Ϫ neurons and led to reduced I Ca in all cases (Fig. 3, A-C) . The blocking efficiency concerning the peak amplitudes ranged from 30% to 46% in WT neurons, from 13% to 25% in Ca v 1.3 Ϫ/Ϫ neurons, and from 21% to 34% in Ca v 1.2DHP Ϫ/Ϫ neurons (Fig. 3D) . In all three cases, the blocking efficiency was statistically significant, with mean values amounting to 39.3 Ϯ 1.8% (n ϭ 8, P ϭ 6 e Ϫ4 ) in WT neurons, 22.2 Ϯ 1.9% (n ϭ 6, P ϭ 0.0049) in Ca v 1.3 Ϫ/Ϫ neurons, and 29.6 Ϯ 2.2% (n ϭ 6, P ϭ 4.4 e Ϫ5 ) in Ca v 1.2DHP Ϫ/Ϫ neurons (Fig. 3D) . Furthermore, the blockade was significantly higher in WT neurons compared with Ca v 1.3 Ϫ/Ϫ (P ϭ 3 e Ϫ5 ) and Ca v 1.2DHP Ϫ/Ϫ (P ϭ 0.0042) neurons (Fig. 3E) . The isradipine-based results indicate a contribution of ϳ40% by L-type channels to I Ca in WT LSO neurons at P12, similar to the situation found for nifedipine. Of these 40%, ϳ30% appears to be contributed by Ca v 1.3 subunits and the remaining 10% by Ca v 1.2 subunits, again in accordance with the nifedipine-based observations. When both drugs were compared, the reduction of I Ca peak amplitudes by isradipine did not differ significantly from that seen under nifedipine (WT: P ϭ 0.26, Ca v 1.3 Ϫ/Ϫ : P ϭ 0.65, and Ca v 1.2DHP Ϫ/Ϫ : P ϭ 0.93), confirming that both substances, at the concentrations used, indeed specifically block L-type channels in LSO neurons and with equal efficiency.
Fitting the current-voltage relationships with a Boltzmann equation yielded significantly different V 1/2 values for WT and Ca v 1.3 Ϫ/Ϫ LSO neurons (WT: Ϫ24.1 Ϯ 1.0 mV, n ϭ 28; Ca v 1.3 Ϫ/Ϫ : Ϫ19.7 Ϯ 0.9 mV, n ϭ 35, P ϭ 2 e Ϫ3 ). The shift toward more positive values is in accordance with the fact that Ca v 1.3 subunits are activated at more negative voltages than Ca v 1.2 channels. As expected, the V 1/2 value for Ca v 1.2DHP neurons (P ϭ 0.27). These results provide further evidence for the coexistence of functional Ca v 1.3 and Ca v 1.2 channels in LSO neurons. Moreover, they corroborate the idea that Ca v 1.2DHP Ϫ/Ϫ mice are a valid model to pharmacologically isolate Ca v 1.3 from the other L-type channel subtype.
I Ca mediated by P/Q-and N-type channels in P12 mice. The finding that 55-60% of the I Ca amplitude remained unblocked by the DHP antagonists nifedipine and isradipine in WT LSO neurons at P12 led us to suggest that these cells possess other types of functional HVACCs aside from L-type channels, e.g., P/Q-and/or N-type channels. To tackle this suggestion, we performed the next series of experiments and applied the specific P/Q-type antagonist -agatoxin IVA (600 nM) or the specific N-type antagonist -conotoxin GVIA (2 M). -Agatoxin IVA reduced I Ca in both WT (Fig. 4, A and B) and Ca v 1.3 Ϫ/Ϫ (Fig. 4, C and D) neurons. The amount of blockade ranged from 6% to 51% in WT neurons (n ϭ 9) and from 8% to 34% in Ca v 1.3 Ϫ/Ϫ neurons (n ϭ 9; Fig. 5 , E and F). On average, peak amplitudes were significantly reduced by 28.6 Ϯ 4.3% (WT neurons, P ϭ 0.0016) and 22.8 Ϯ 2.7% (Ca v 1.3 Ϫ/Ϫ neurons, P ϭ 3 e Ϫ4 ). The blockade by -agatoxin IVA did not differ in WT versus Ca v 1.3 Ϫ/Ϫ neurons (P ϭ 0.27), indicating that P/Q-type channels do not compensate for Ca v 1.3 deficiency. However, this issue will be addressed more thoroughly below.
-Conotoxin GVIA also resulted in reduced I Ca in both genotypes (Fig. 5, A-D) . The effect ranged from 3% to 41% in WT neurons and from 12% to 35% in Ca v 1.3 Ϫ/Ϫ neurons, with mean values of 21.7 Ϯ 3.4% (n ϭ 10, P ϭ 5 e Ϫ4 ) and 25.5 Ϯ 2.3% (n ϭ 10, P ϭ 4 e Ϫ6 ), respectively (Fig. 5, E and F) . Again, there was no significant difference between WT and Ca v 1.3 Ϫ/Ϫ neurons (P ϭ 0.36; Fig. 5F ). Taken together, these results demonstrate a considerable contribution of P/Q-and N-type channels to I Ca in LSO neurons at P12. Moreover, both types contribute to a similar amount at P12 (WT: 29% P/Qtype channels and 22% N-type channels; Ca v 1.3 Ϫ/Ϫ : 23% P/Q-type channels and 26% N-type channels).
I Ca mediated by L-type channels in P4 mice. Ca v 1.3 channels are already functional in IHCs of neonatal mice, many days before hearing onset (at P12) and at times when spontaneous activity in the cochlea drives the synaptic activity in the subsequent auditory pathway (Tritsch et al. 2010) . Spontaneous neuronal activity patterns appear to be crucial for neuron survival and the generation of orderly connections in the auditory system (Friauf and Lohmann 1999; Kandler et al. 2009; Kandler and Gillespie 2005) . To determine whether the repertoire of HVACCs undergoes developmental changes in the LSO, we monitored HVACC-mediated currents in LSO neurons of P4 mice. Already at this early age, I Ca was activated. Application of nifedipine caused a considerable and statistically significant reduction of the I Ca peak amplitude in all three genotypes (Fig. 6, A-F) . The reduction ranged from 10% to 58% in WT neurons, from 3% to 39% in Ca v 1.3 Ϫ/Ϫ neurons, and from 22% to 39% in Ca v 1.2DHP Ϫ/Ϫ neurons (Fig. 6G) . The corresponding mean values were 36.4 Ϯ 5.1% (n ϭ 10, P ϭ 0.010), 19.9 Ϯ 3.7% (n ϭ 9, P ϭ 0.010), and 29.8 Ϯ 2.0% (n ϭ 11, P ϭ 2.7 e Ϫ5 ; Fig. 6H ). Significance was achieved between WT and Ca v 1.3 Ϫ/Ϫ mice (P ϭ 0.020) but not between WT and Ca v 1.2DHP Ϫ/Ϫ mice (P ϭ 0.22). Together, these results show that LSO neurons at P4 harbor functional L-type channels, which appear to contribute by 36% to total I Ca . Moreover, they indicate that, like at P12, the relative contribution of Ca v 1.3 channels to I Ca is higher than that of Ca v 1.2 channels (30% vs. 6%).
I Ca mediated by P/Q-and N-type channels in P4 mice. To assess the contribution of P/Q-and N-type Ca 2ϩ channels in LSO neurons at P4, the same approach was chosen as with P12 neurons, i.e., I Ca was recorded under control conditions and in the presence of the P/Q-type channel inhibitor -agatoxin IVA or the N-type channel inhibitor -conotoxin GVIA. Application of -agatoxin IVA significantly reduced I Ca in both genotypes (Fig. 7, A-D) . The blockade ranged from 14% to 52% in WT mice and from 5% to 50% in Ca v 1.3 Ϫ/Ϫ mice, with mean values of 27.7 Ϯ 3.3% (n ϭ 11, P ϭ 0.0022) in WT mice and 22.0 Ϯ 4.4% (n ϭ 10, P ϭ 0.0049) in Ca v 1.3 Ϫ/Ϫ (Fig. 8,  E and F) . The difference between genotypes was not statistically significant (P ϭ 0.30).
Application of -conotoxin GVIA also reduced peak amplitudes (Fig. 8, A-D) . Blocking efficiency ranged from 14% to 59% in WT mice and from 13% to 41% in Ca v 1.3 Ϫ/Ϫ mice (Fig. 8E) . On average, peak amplitudes were reduced by 29.2 Ϯ 4.0% (n ϭ 12, P ϭ 4.4 e Ϫ5 ) in WT mice and by 25.8 Ϯ 3.8% (n ϭ 9, P ϭ 0.0022) in Ca v 1.3 Ϫ/Ϫ mice (Fig. 8F) , with no significant difference between genotypes (P ϭ 0.56). These data show that, aside from L-type channels, LSO neurons at P4 also possess functional P/Q-and N-type channels with considerable and similar contributions (WT: 28% P/Q-type channels and 29% N-type channels; Ca v 1.3 Ϫ/Ϫ : 22% P/Q-type channels and 26% N-type channels). As in the case of WT mice at P12, the contribution was less than that of L-type channels.
Comparison between P4 and P12. We next compared the P4 data with those obtained at P12 with the aim to assess possible developmental changes. The comparison revealed that nifedipine blocked I Ca peak amplitudes in WT neurons at P12 in a similar way as at P4 (P ϭ 0.24, Fig. 9A and Table 1 ). This implies no major, if any, developmental changes in L-type channels. Concerning -agatoxin IVA and -conotoxin GVIA blockade, there were also no significant differences between ages in WT neurons (P ϭ 0.87 and P ϭ 0.18; Fig. 9A and Table 1 ). Together, these data provide confirmatory evidence for the assumption that the repertoire of HVACCs does not change in LSO neurons between neonatal and juvenile mice. In Ca v 1.3 Ϫ/Ϫ mice, there was virtually no difference in all three pharmacological treatments (P ϭ 0.96, P ϭ 0.89, and P ϭ 0.95; Fig. 9A and Table 1 ), indicating that the loss of Ca v 1.3 channels does not result in age-related changes of the fractions of L-, P/Q-, and N-type channels.
Concerning the absolute current amplitudes and their development, a significant increase occurred with age in WT neurons (P4: Ϫ555.5 Ϯ 59.8 pA, n ϭ 25; P12: Ϫ915.8 Ϯ 47.9 pA, n ϭ 34, P ϭ 1.4 e Ϫ5 ). Likewise, absolute current amplitudes increased with age in Ca v 1.2DHP Ϫ/Ϫ neurons (P4: Ϫ481.5 Ϯ 39.0 pA, n ϭ 11; P12: Ϫ883.4 Ϯ 100.3 pA, n ϭ 16, P ϭ 0.0014). In contrast, no such developmental increase was Ϫ/Ϫ neurons (P4: Ϫ667.6 Ϯ 48.9 pA, n ϭ 21; P12: Ϫ655.9 Ϯ 58.6 pA, n ϭ 27, P ϭ 0.88), implying a disturbed development of Ca 2ϩ channel function upon loss of the Ca v 1.3 subtype. This was also reflected by the observation that the peak amplitude of WT neurons at P4 did not differ from that of Ca v 1.3 Ϫ/Ϫ neurons at P4 (P ϭ 0.16), whereas it was significantly lower in Ca v 1.3 Ϫ/Ϫ neurons at P12 than in their WT counterparts at P12 (P ϭ 9.8 e Ϫ4 ). As expected, there was no difference between the peak amplitudes of WT and Ca v 1.2DHP Ϫ/Ϫ neurons at P4 and P12 (P ϭ 0.31 and P ϭ 0.74). In line with this, a reevaluation of the peak amplitudes (at Ϫ10 mV) from the samples shown in Fig. 2, B and F, also demonstrated no difference between WT and Ca v 1.2DHP Ϫ/Ϫ neurons at P12 (WT: Ϫ862.7 Ϯ 96.5 pA, n ϭ 10; Ca V 1.2DHP Ϫ/Ϫ : Ϫ675.7 Ϯ 85.5 pA, n ϭ 9, P ϭ 0.17). In a final series of electrophysiological experiments, we analyzed the development of whole cell capacitance, which is Values for the peak current density of I Ca ranged from Ϫ10.7 to Ϫ41.1 pA/pF in WT neurons at P4 and from Ϫ21.3 to Ϫ113.1 pA/pF in WT neurons at P12 (Fig. 9B) . The corresponding data for Ca v 1.3 Ϫ/Ϫ neurons were Ϫ12.0 to Ϫ45.7 pA/pF at P4 and Ϫ20.7 to Ϫ83.2 pA/pF at P12 (Fig.  9B) . From these values, a significant developmental increase became evident in both WT (P4: Ϫ20.0 Ϯ 1.6 pA/pF, n ϭ 24; P12: Ϫ51.7 Ϯ 3.8 pA/pF, n ϭ 35, P ϭ 2.8 e Ϫ9 by MannWhitney U-test; Fig. 9C ) and Ca v 1.3 Ϫ/Ϫ neurons (P4: Ϫ26.0 Ϯ 1.9 pA/pF, n ϭ 21; P12: Ϫ37.6 Ϯ 3.1 pA/pF, n ϭ 28, P ϭ 0.0026 by Mann-Whitney U-test; Fig. 9C ), similar to the findings in I Ca amplitude analyses. At P4, the current density was significantly lower in WT than in Ca v 1.3 Ϫ/Ϫ neurons (P ϭ 0.021), whereas the opposite finding was obtained at P12 (P ϭ 0.0052 by Mann-Whitney U-test; Fig. 9C ). At present, we do not have a straightforward explanation for this surprising result.
R-type channels and compensatory changes in the proportion of HVACC subtypes. When the percentages of blockade obtained by nifedipine, -agatoxin IVA, and -conotoxin GVIA were added in WT and Ca v 1.3 Ϫ/Ϫ LSO neurons at both P4 and P12, the sum was Ͻ100% in each of the four cases, indicating the presence of another HVACC channel subtype aside from L-, P/Q-, and N-type channels (Fig. 10) . This subtype most likely comprises R-type channels, and the contribution amounted to 7% in WT neurons at P4, 4% in WT neurons at P12, 32% in Ca v 1.3 Ϫ/Ϫ neurons at P4, and 31% in Ca v 1.3 Ϫ/Ϫ neurons at P12. The lack of age-related increases of I Ca in Ca v 1.3 Ϫ/Ϫ LSO neurons between P4 and P12 demonstrates a disturbed development, but it cannot provide information about changes in the relative contribution of various HVACC subtypes. To address this issue, we calculated the relative contribution of the four groups of Ca 2ϩ channels that contributed to I Ca in WT neurons after the fraction attributed to Ca v 1.3 subunits was subtracted. These corrected values ("WT corr." in Fig. 10 ) can thus be directly compared with those obtained in Ca v 1.3 Ϫ/Ϫ neurons. It became obvious that Ca v 1.2 and R-type channels appear to contribute to I Ca to a larger extent in Ca v 1.3 Ϫ/Ϫ neurons at P4 than they do in WT neurons. In contrast, the contribution of P/Q-and N-type channels was considerably reduced in Ca v 1.3 Ϫ/Ϫ neurons. At P12, however, the relative contribution of Ca v 1.2 and N-type channels appeared to be similar in both genotypes, whereas P/Q-type channels seemed to be downregulated and R-type channels upregulated. These results are indicative of a reorganization of functional HVACCs in the absence of Ca v 1.3 subunits and also of ongoing changes with age. Nevertheless, an increase of I Ca was obviously not achieved through these changes.
Quantitative Ϫ/Ϫ LSO neurons. The results obtained in our electrophysiological analyses demonstrated the contribution of at least three different subtypes of HVACCs to I Ca in LSO neurons (L-, N-, and P/Q-type channels) and also indicated the presence of R-type channels. In addition, we found evidence that Ca v 1.2 does not compensate for the absence of the Ca v 1.3 subunit in Ca v 1.3 Ϫ/Ϫ mice at P12. To assess whether these data are paralleled at the transcriptional level, we examined the mRNA expression of individual HVACC ␣ 1 -subunits in the LSO of WT and Ca v 1.3 Ϫ/Ϫ animals at P12. By means of quantitative RT-PCR, we found that Ca v 1.2 contributes to 49 Ϯ 2.4% (n ϭ 3) of all L-type transcripts and Ca v 1.3 to 51%, with the majority (40 Ϯ 2.1%) being attributed to the long splice variant Ca v 1.3-42 and a minor part (11 Ϯ 0.3%) to the short slice variant Ca v 1.3-42a (Fig. 11A) . The presence of both variants is in accordance with recent data obtained in various brain regions (Singh et al. 2008) . We also quantified the relative abundance of the transcripts for P/Q-, N-, and R-type channels and compared them with the data obtained for the L-type transcripts (assessment of GAPDH transcripts served as an efficiency reference). We found lower levels for the three L-type transcripts than for each of the three non-L-type transcripts (Ca v 2.1, Ca v 2.2, and Ca v 2.3; Fig. 11B ). Additionally, we tested for changes of subunit expression in Ca v 1.3 Ϫ/Ϫ mice via GAPDH-normalized ⌬⌬C t analysis (Marcantoni et al. 2010) . As shown in Fig. 11C , the ratio of Ca v 2.1 mRNA expression was not different between WT and Ca v 1.3 Ϫ/Ϫ mice (WT/knockout: 1.03 Ϯ 0.1, n ϭ 3, P ϭ 0.98), but a significant increase was evident for Ca v 1.2 (WT/knockout: 1.47 Ϯ 0.58, P ϭ 0.016), Ca v 2.2 (WT/knockout: 1.73 Ϯ 0.06, P ϭ 1.7 e Ϫ5 ), and Ca v 2.3 (WT/knockout: 2.04 Ϯ 0.15, P ϭ 3.9 e Ϫ/Ϫ mice were used. The six major results can be summarized as follows: first, LSO neurons express functional L-, P/Q-, N-, and, most likely, R-type channels. These results were corroborated by demonstrating gene expression for five ␣-subunits (L-type: ␣ 1C and ␣ 1D , N-type: ␣ 1B , P/Q-type: ␣ 1A , and R-type: ␣ 1E ). Moreover, at least two splice variants encoding for Ca v 1.3 are expressed and equally contribute to the L-type component. Second, both L-type channels, Ca v 1.2 and Ca v 1.3, are functional. Third, at P12, ϳ45% of I Ca is mediated by L-type channels, 29% by P/Q-type channels, 22% by N-type channel, and 4% most likely by R-type channels. Fourth, Ca v 1.3 channels contribute more effectively to the L-type-mediated portion of I Ca than Ca v 1.2 subunits. Fifth, the WT profile of HVACCs at P12 is similar to that at P4. Finally, the loss of the ␣ 1D -subunit in Ca v 1.3 Ϫ/Ϫ mice appears to be accompanied by changes in the contribution of other functional HVACCs, but these changes cannot reestablish normal I Ca amplitudes.
Identification and functional characterization of LSO neurons. Based on their morphological characteristics, three distinct types of neurons were identified in C57BL/6 mice (Ollo and Schwartz 1979) , with spindle-shaped bipolar cells being the predominant type. In the present study, we chose LSO neurons according to their oval, spindle-shaped somata and their central location in the LSO. As we used a Cs-based intracellular solution, we could not use criteria like firing pattern, resting membrane potential, K ϩ -mediated outward currents, or hyperpolarization-activated inward currents for cell identification. Nevertheless, our whole cell capacitance values are in very good accord with data from mouse and rat principal LSO neurons (Barnes-Davies et al. 2004; Dodson et al. 2002; Leao et al. 2006; Sterenborg et al. 2010) . We therefore conclude that our recordings originated from principal cells and thus from a homogenous population. Indeed, sporadic biocytin fills and subsequent morphological analysis confirmed this conclusion.
The unchanged whole cell capacitance values of LSO neurons between WT and Ca v 1.3 Ϫ/Ϫ neurons do not conflict with our previous finding that the somadendritic field of bipolar LSO neurons was 81% larger in Ca v 1.3 Ϫ/Ϫ animals (Hirtz et al. 2011) (Fig. 7G) . The size of the somadendritic field is a measure of the extent of dendritic arbors (Elston and Rosa 1997) , yet it does not correlate with the dendritic complexity. The complexity is rather illustrated by the number of dendritic segments, i.e., all branches of low and high order (Duan et al. 2002; Jacobs et al. 1993) . Hirtz et al. (2011) recently assessed the complexity by the concentric shell method (Sholl 1953) and found no changes between WT and Ca v 1.3 Ϫ/Ϫ bipolar LSO neurons (Fig. 7E) , providing morphological evidence for unchanged whole cell capacitance. Contribution of different types of HVACCs to I Ca . Pharmacological studies on rodent bushy cells of the anteroventral cochlear nuclear complex (Doughty et al. 1998) , neurons in the inferior colliculus (N'Gouemo and Morad 2003), octopus cells of the posteroventral cochlear nuclear complex (Bal and Oertel 2007) , medial superior olive and medial nucleus of the trapezoid body neurons (Barnes-Davies et al. 2001; Leao et al. 2004) consistently identified multiple components in generating the HVACCs and a significant contribution of L-type channels, albeit with considerable variation in the percentages. Like us, the authors concluded that the current that remained in the presence of the blocker cocktail was mediated by R-type channels. The reasons for the specific expression patterns of one or the other channel type in each particular nucleus are enigmatic. Due to the distinct structure, biophysical characteristics, and regulation patterns, a repertoire of HVACC subtypes provides a flexible array of Ca 2ϩ entry pathways, enabling fine-tuned responses to changes in membrane potential. In particular, the potential for diversity in modulation (via phosphorylation, cAMP-dependent protein kinase pathways, and G proteins; literature cited in Catterall 2000) might explain the seemingly redundant expression of L-, P/Q-, N-, and R-type Ca 2ϩ channels. Pharmacological considerations. Quantitative studies of I Ca amplitudes may be compromised by some pharmacological constraints. First, the drugs may not have high channel specificity. At the concentration used here, -agatoxin IVA effectively inhibits current through P/Q-type channels but not through N-or L-type channels (literature cited in McDonough et al. 2002) . Concerning -conotoxin GVIA, its high specificity and potency on N-type channels have been consistently reported (Ichida et al. 2005; McCleskey et al. 1987; McDonough et al. 2002; Nielsen et al. 2000) . In our experiments, we did not apply the blockers sequentially and in combination. If redundancy of blocker specificity is a serious problem, the summed contribution of all I Ca blocked by the drugs should exceed 100%, as observed in the inferior colliculus (N'Gouemo and Morad 2003). However, in none of our experiments was this the case. Second, Ca v 1.3 and Ca v 1.2 may not be equally inhibitable in LSO neurons by nifedipine and isradipine. In fact, Ca v 1.3 channels have been reported less sensitive to these drugs than Ca v 1.2 channels (Helton et al. 2005; Lipscombe et al. 2004; Xu and Lipscombe 2001) . However, the similarities between our pharmacological results and those gained with the two mouse mutant strains suggest that this concern is negligible at the concentrations used.
Developmental aspects. Both at P4 and P12, all HVACC types contributed to I Ca in WT LSO neurons, but none of the channel types displayed considerable age-dependent changes (cf. Fig. 10 and Table 1 ). In contrast, an increase of the P/Q-type fraction and a concomitant decrease of the R-type fraction have been reported in the rat inferior colliculus (N'Gouemo and Morad 2003; N'Gouemo and Rittenhouse 2000) . Likewise, recordings from presynaptic calyces of Held terminals showed that N-and R-type-mediated currents disappear after P10, whereas the P/Q-type fraction increases and becomes predominant (Iwasaki and Takahashi 1998) . It should be noted that the authors identified no L-type fraction during the whole developmental period examined, consistent with the idea that these channels are predominantly located postsynaptically in the somadendritic plasma membrane.
HVACCs in Ca v 1.3
Ϫ/Ϫ neurons. Our electrophysiological data revealed that Ca v 1.3 and Ca v 1.2 channels appear to contribute to the L-type-mediated I Ca amplitudes with a ratio of 2:1 at P12 (30%:15% of total I Ca ; cf. Fig. 10 ). Upon ablation of the Ca v 1.3 gene, there was no obvious change in Ca v 1.2 or N-type channels, but P/Q-and R-type channels appeared to be down-and upregulated, respectively. In contrast, our quantitative RT-PCR results revealed increased expression levels for Ca v 1.2 as well as N-type mRNA in Ca v 1.3 Ϫ/Ϫ neurons and unchanged levels of P/Q-type transcripts (cf. Fig. 11C ). This indicates that the deficiency of Ca v 1.3 channels in LSO neurons is compensated by other HVACCs at the transcriptional level.
Compensatory changes in the HVACC repertoire were observed in Purkinje cells of tottering mice, which possess a recessive mutation of the ␣ 1A (P/Q-type) subunit. Although ␣ 1C (Ca v 1.2) mRNA expression is significantly upregulated (Campbell and Hess 1999) , this does not prevent the tottering phenotype and ataxia; rather, it may cause them. A similar form of compensation has been described in embryonic cardiomyocytes, where deletion of the Ca v 1.2 gene results in increased expression of genes encoding for Ca v 1.1, Ca v 1.3, and Ca v 3.1 at both the mRNA and protein levels (Xu et al. 2003) . As shown by RT-PCR, the upregulation was most pronounced for Ca v 1.3 (4-fold). Nevertheless, as Ca v 1.2 Ϫ/Ϫ mice die before embryonic day 14 (Seisenberger et al. 2000) , this implies that the substitution does not fully restore function. This is in line with our seemingly paradoxical findings presented here showing that, although Ca v channel genes are upregulated in Ca v 1.3 Ϫ/Ϫ mice, this does not result in the restoration of normal I Ca amplitudes. Our finding that I Ca amplitudes in Ca v 1.3 Ϫ/Ϫ mice do not increase with age, although they do so in WT animals, provides further evidence for a disturbed development of functional Ca 2ϩ channels in these animals. An open question concerns the contribution of R-type channels to I Ca in LSO neurons. In unison with many other groups (Bal and Oertel 2007; Barnes-Davies et al. 2001; N'Gouemo and Morad 2003) , we reason that the remnant current left after pharmacological blockade with nifedipine, -agatoxin IVA, and -conotoxin GIVA was mediated by this channel type. It will be interesting to identify functional R-type channels in the LSO, e.g., with a pharmacological inhibitor from tarantula venom (Bloodgood and Sabatini 2007; Newcomb et al. 1998; Plotkin et al. 2011) . Of further interest is whether they are upregulated in Ca v 1.3 Ϫ/Ϫ neurons, as implied by our electrophysiological and quantitative RT-PCR results (cf. Figs. 10 and  11C) .
With regard to a quantitative description of gene expression, previous studies compared mRNA levels with protein levels and concluded that the correlation was poor (de Sousa et al. 2009; Maier et al. 2009 ). It appears that the abundance of proteins is predominantly controlled at the level of translation (Schwanhausser et al. 2011) . We therefore suppose that different HVACCs can compensate for each other in mRNA expression but may not be able to functionally substitute the lack of one specific channel subtype. Future studies will be required to provide more insight into how HVACC expression and function are regulated.
Conclusions. In summary, our study demonstrates the presence of virtually all subtypes of HVACCs (L-, P/Q-, N-, and most likely R-type) in mouse LSO neurons at both juvenile and neonatal stages. In Ca v 1.3 Ϫ/Ϫ mice, the LSO is strikingly malformed and comprises about one-third fewer neurons (Hirtz et al. 2011) . As these mice lack cochlea-driven activity, their central auditory system is thus deprived from peripheral input. Therefore, the LSO defects can be transsynaptic, i.e., downstream from cochlear dysfunction, as previously reported in cochlear ablation studies (Born and Rubel 1985; Sanes et al. 1992) . However, the presence of functional Ca v 1.3 channels in LSO neurons, as reported here, offers an alternative scenario, namely, that on-site loss of the channels in the LSO neurons themselves contributes significantly to the malformation. Generation and analysis of tissue-specific Ca v 1.3 Ϫ/Ϫ animals are under way to distinguish between cochlear (peripheral) and on-site (central) effects, including the relative importance of each . Likewise, morphometric analyses of the LSO in other knockout models with cochlear dysfunction, such as prosaposin Ϫ/Ϫ mice (Akil et al. 2006) , otoferlin otof mice (Longo-Guess et al. 2007) , and dn/dn mice (Youssoufian et al. 2008) , will likely contribute to this open issue.
